0001493152-21-030884.txt : 20211208
0001493152-21-030884.hdr.sgml : 20211208
20211208215845
ACCESSION NUMBER: 0001493152-21-030884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211208
DATE AS OF CHANGE: 20211208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilbert Mark John
CENTRAL INDEX KEY: 0001897698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 211480166
MAIL ADDRESS:
STREET 1: 13731 NORTHWOOD RD., NW
CITY: SEATTLE
STATE: WA
ZIP: 98177
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 347-480-9760
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0306
4
2021-12-01
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001897698
Gilbert Mark John
C/O INDAPTUS THERAPEUTICS, INC.
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Stock Option (right to buy)
5.35
2021-12-01
4
A
0
20000
0
A
2031-12-01
Common Stock
20000
20000
D
One hundred percent of the stock options vest and become exercisable on December 1, 2022.
/s/ Mark J. Gilbert
2021-12-08